Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Pontesilli

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Immunology|October 27, 1997
CD28 costimulation and T lymphocyte proliferative responses in HIV-1 infectionM Carlesimo, O Pontesilli, A R Varani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1997
HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDSS H van der Burg, M R Klein, O Pontesilli, et al.
Diagnostic Immunology|January 1, 1986
Salivary IgA levels in normal childrenR D'Amelio, R Bonomo, G P D'Offizi, et al.
The Journal of Infectious Diseases|June 3, 1999
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapyO Pontesilli, S Kerkhof-Garde, D W Notermans, et al.
Clinical and Experimental Immunology|June 1, 1995
HIV-specific lymphoproliferative responses in asymptomatic HIV-infected individualsO Pontesilli, M Carlesimo, A R Varani, et al.
The Journal of General Virology|August 1, 1997
Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDSC A van Baalen, O Pontesilli, R C Huisman, et al.
AIDS (London, England)|April 16, 1998
Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol TeamO Pontesilli, E C Guerra, A Ammassari, et al.
The Journal of Infectious Diseases|October 23, 1997
Long-term evaluation of cellular immunity during antiretroviral therapy and immunization with human immunodeficiency virus type 1 (HIV-1) Env glycoprotein in HIV-1-infected personsM Carlesimo, O Pontesilli, E C Guerra, et al.
Antibiotics and Chemotherapy|January 1, 1996
Immunological aspects of patients with HIV-1 disease following immunization with recombinant gp160 (VaxSyn)E Guerra, G Ricci, M Carlesimo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4+ T cells by at least four unrelated HLA-DR moleculesS H van der Burg, K M Kwappenberg, A Geluk, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Immunology|October 27, 1997
CD28 costimulation and T lymphocyte proliferative responses in HIV-1 infectionM Carlesimo, O Pontesilli, A R Varani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1997
HIV-1 reverse transcriptase-specific CTL against conserved epitopes do not protect against progression to AIDSS H van der Burg, M R Klein, O Pontesilli, et al.
Diagnostic Immunology|January 1, 1986
Salivary IgA levels in normal childrenR D'Amelio, R Bonomo, G P D'Offizi, et al.
The Journal of Infectious Diseases|June 3, 1999
Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapyO Pontesilli, S Kerkhof-Garde, D W Notermans, et al.
Clinical and Experimental Immunology|June 1, 1995
HIV-specific lymphoproliferative responses in asymptomatic HIV-infected individualsO Pontesilli, M Carlesimo, A R Varani, et al.
The Journal of General Virology|August 1, 1997
Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDSC A van Baalen, O Pontesilli, R C Huisman, et al.
AIDS (London, England)|April 16, 1998
Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol TeamO Pontesilli, E C Guerra, A Ammassari, et al.
The Journal of Infectious Diseases|October 23, 1997
Long-term evaluation of cellular immunity during antiretroviral therapy and immunization with human immunodeficiency virus type 1 (HIV-1) Env glycoprotein in HIV-1-infected personsM Carlesimo, O Pontesilli, E C Guerra, et al.
Antibiotics and Chemotherapy|January 1, 1996
Immunological aspects of patients with HIV-1 disease following immunization with recombinant gp160 (VaxSyn)E Guerra, G Ricci, M Carlesimo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4+ T cells by at least four unrelated HLA-DR moleculesS H van der Burg, K M Kwappenberg, A Geluk, et al.
Pageof 5